Table 3. Comparison of assessment variables of the patients.
Variable | Pre-treatment | 6th week | p-value |
---|---|---|---|
Severity of incontinence (Pad test) | 55 (115–25) | 7 (14–1) | <0.001 |
Frequency | 12 (15–10) | 7 (8–6) | <0.001 |
Nocturia | 3 (4–2) | 1 (2–1) | <0.001 |
Incontinence episodes | 4 (7–3) | 1 (2–1) | <0.001 |
Number of pads | 3 (4–2) | 1 (1–0) | <0.001 |
Symptom severity (OAB-V8) | 28 (33–22) | 6 (8–4) | <0.001 |
Quality of life (IIQ7) | 11 (16–5) | 2 (3–1) | <0.001 |
Values are presented as median (ınterquartile range); IQR=3rd quartile–1st quartile.
OAB-V8, Overactive Bladder Questionnaire; IIQ-7, Incontinence Impact Questionnaire.
p-value by Wilcoxon signed-rank test.